Bank of Baroda Stock in Focus Today After $600 Million NMC Settlement; Analysts Watch Q1 Earnings Impact

Bank of Baroda stock is in focus today after the state-run lender agreed to pay $600 million, around Rs 5,700 crore, to settle a long-running legal dispute tied to the collapse of NMC Health, with the stock falling more than 4 percent yesterday to close at Rs 260.15 on the BSE as investors weighed the size of the one-time payout against the bank’s otherwise strong quarterly business update.

The settlement, paid through the bank’s Abu Dhabi branch, resolves claims brought by the joint administrators of NMC Health PLC, NMC Healthcare and NMC Holding, with Bank of Baroda having been one of three defendants in a $5.4 billion claim linked to the healthcare group’s 2020 collapse. The bank has denied any wrongdoing, and the settlement was reached without admission of liability. This is a key data point for anyone tracking the Bank of Baroda stock today.

Click Here – Get Free Investment Predictions

Why Bank of Baroda Stock Fell on the Settlement News

Bank of Baroda was the top loser among Nifty Bank constituents yesterday, sliding as much as 5.08 percent intraday to a low of Rs 257.70 even as the broader banking index stayed in positive territory. The scale of the reaction reflects the size of the payout relative to the bank’s earnings base, with the settlement amount of roughly Rs 5,700 crore broadly equivalent to Bank of Baroda’s entire net profit of Rs 5,616 crore for the January to March quarter of FY26. Investors watching the Bank of Baroda stock should note this development closely.

The NMC Health dispute stemmed from the healthcare group’s dramatic 2020 collapse, once valued at $8.6 billion and operating across 19 countries, after a short seller report exposed billions of dollars in previously undisclosed debt. This legacy dispute had weighed on Bank of Baroda stock as an overhang for several years. Administrators subsequently pursued claims against NMC founder BR Shetty, former CEO Prasanth Manghat and Bank of Baroda, alleging the bank had facilitated the fraud, an allegation the bank has consistently denied. This detail is central to the near term outlook on the Bank of Baroda stock.

Bank of Baroda Q1 FY27 Business Update

Metric	Value
CMP (Yesterday’s Close)	Rs 260.15
Day Change (Yesterday)	-4.18%
Global Advances (Q1 FY27)	Rs 14.17 Lakh Cr (+17.42% YoY)
Global Deposits (Q1 FY27)	Rs 16.34 Lakh Cr (+13.81% YoY)
Global Business (Q1 FY27)	Rs 30.51 Lakh Cr (+15.46% YoY)
NMC Settlement Amount	$600 Mn (~Rs 5,700 Cr)

Check the Univest Screener for Live PSU Banking Sector Data

Alongside the settlement news, Bank of Baroda stock is also in focus on clearly strong core operating metrics, with domestic advances rising 16.14 percent year on year to Rs 11.51 lakh crore and domestic deposits up 14.74 percent to Rs 13.82 lakh crore for the quarter ended June 30, 2026, growth that outpaces the broader banking system average.

What Analysts Are Watching for Bank of Baroda Stock

Anand Rathi Share and Stock Brokers has flagged Bank of Baroda stock among its top picks in the PSU banking space, maintaining a Buy rating with a target price of Rs 329, as part of a broader constructive view on India’s banking sector where system credit growth accelerated to 17.7 percent year on year in May 2026, with public sector banks outpacing private peers for a ninth straight month. The brokerage’s positive stance sits alongside the settlement news, suggesting the market’s near term focus on the one-time payout has not altered the underlying operational thesis for the stock.

The key monitorable for Bank of Baroda stock going into full Q1 FY27 results will be how the bank accounts for the settlement in its quarterly numbers, and whether the one-time outflow is absorbed without materially denting capital adequacy ratios, given the payout is roughly equal to an entire quarter’s profit. Investors and analysts are also watching whether the gap between loan growth of 17.4 percent and deposit growth of 13.8 percent puts pressure on the credit-deposit ratio and, in turn, net interest margins in coming quarters.

Quick take: Bank of Baroda stock’s reaction reflects the size of the one-time NMC payout more than any change in the bank’s core operating trajectory, with Q1 business growth remaining strong even as the settlement’s full earnings impact will only be confirmed when quarterly results are announced.

Download the Univest iOS App or Univest Android App to track Bank of Baroda’s live price and quarterly updates.

Key Risks to Watch on Bank of Baroda Stock

NMC founder BR Shetty and former CEO Prasanth Manghat remain defendants in the case, with the ADGM trial scheduled to run until July 9, 2026, meaning further developments in the broader litigation could keep the story in headlines even though Bank of Baroda’s own settlement is concluded. Investors should also note that Bank of Baroda stock has fallen nearly 15 percent over the past six months, and confirmation of how the settlement flows through reported earnings will be an important data point once full quarterly results are released.

Conclusion

Bank of Baroda stock remains in focus today as the market continues to digest yesterday’s $600 million NMC Health settlement alongside a strong Q1 FY27 business update showing double digit growth in advances and deposits. With Anand Rathi maintaining a Buy rating and Rs 329 target despite the settlement, and the payout roughly matching a full quarter’s profit, investors should watch the bank’s full Q1 results for clarity on the settlement’s precise earnings and capital adequacy impact. This article is for educational purposes and is not investment advice; consult a SEBI-registered investment adviser before making any investment decision.

FAQs on Bank of Baroda Stock

1. Why is Bank of Baroda stock in focus today?

Ans. Bank of Baroda stock is in focus after the bank agreed to a $600 million settlement with NMC Health’s joint administrators, with the stock falling over 4 percent yesterday even as the bank reported strong Q1 FY27 business growth.

2. What was the NMC Health case about?

Ans. Bank of Baroda was one of three defendants in a $5.4 billion claim brought by NMC Health’s administrators following the healthcare group’s 2020 collapse, with allegations the bank facilitated fraud, which Bank of Baroda has denied.

3. How much did Bank of Baroda pay to settle the NMC case?

Ans. Bank of Baroda paid $600 million, approximately Rs 5,700 crore, through its Abu Dhabi branch, without any admission of liability or wrongdoing.

4. What is the brokerage view on Bank of Baroda stock?

Ans. Anand Rathi Share and Stock Brokers has a Buy rating on Bank of Baroda stock with a target price of Rs 329, citing the bank’s position among its top PSU banking picks.

5. How did Bank of Baroda perform in Q1 FY27?

Ans. Global advances grew 17.42 percent year on year to Rs 14.17 lakh crore, global deposits rose 13.81 percent to Rs 16.34 lakh crore, and global business increased 15.46 percent to Rs 30.51 lakh crore.

6. How large is the NMC settlement relative to Bank of Baroda’s earnings?

Ans. The Rs 5,700 crore settlement is broadly equivalent to Bank of Baroda’s entire net profit of Rs 5,616 crore for the January to March quarter of FY26, underscoring why analysts are watching its Q1 FY27 earnings impact closely.